Search
SOLACI Congress
Presentations

MEDIOS DE CONTRASTE; Selección del tipo. Prevención de la nefropatía

solaci
solaci
41
0

2_torresani_ernesto
Ernesto M. Torresani
2014-04-22

SANATORIO MODELO QUILMES. 
Quilmes – Buenos Aires – Argentina

Previous article
How to select the Most Appropriate Device for CAS?
Next article
Ultrasonido Intracoronario. Fundamentos, utilización y estudios clínicos.
solaci
solaci

More articles by this author

Transcatheter Aortic Valve Implantation: Step by Step

solaci - 0
Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   

Implante transcateter de bioprótesis aórtica. Selección de pacientes

solaci - 0
Jorge Belardi2014-04-22Director del Departamento de Cardiología ICBA

Implante Transapical de Bioprotesis Aórtica Autoexpandible en Paciente Compasivo con Estenosis Aórtica Severa contraindicado para otros abordajes

solaci - 0
Cohen Fernando2014-04-22Servicio de Hemodinamia y Cardiología IntervencionistaHospital Italiano de Buenos Aires

Cierre de Orejuela Auricular Izquierda: Técnica y Resultados

solaci - 0
Aníbal Damonte2014-04-22Departamento de Hemodinamia y Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Transcatheter Aortic Valve Implantation: Step by Step

Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   
solaci -
SOLACI Sessionsspot_img

Recent Articles

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Dr. Andrés Rodríguez - 0
Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

Dr. Andrés Rodríguez - 0
The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Dr. Omar Tupayachi - 0
Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Dr. Andrés Rodríguez - 0
Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

Dr. Andrés Rodríguez - 0
The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Dr. Omar Tupayachi - 0
Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

Institutional News

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

solaci - 0
You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

2025 SOLACI Research Grant

solaci - 0
By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy